Properties
What is it?
PAIDOTERIN ANTIGRIFFAL SYRUP READ THE PACKAGE LEAFLET CAREFULLY BEFORE TAKING THE MEDICINE - KEEP THIS LEAFLET AS YOU MAY NEED TO READ IT AGAIN - IF YOU HAVE ANY DOUBTS, CONSULT YOUR DOCTOR OR PHARMACIST - THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU AND SHOULD NOT BE GIVEN TO OTHERS, EVEN IF THEY HAVE THE SAME SYMPTOMS, AS IT MAY BE HARMFUL TO THEM - IF YOU NOTICE THAT ANY SIDE EFFECT CAUSED BY IT IS SERIOUS OR IF ANY SIDE EFFECT NOT LISTED IN THIS LEAFLET OCCURS, INFORM YOUR DOCTOR OR PHARMACIST LEAFLET CONTENTS: 1. WHAT PAIDOTERIN ANTIGRIFFAL SYRUP IS AND WHAT IT IS USED FOR 2. BEFORE TAKING PAIDOTERIN ANTIGRIFFAL SYRUP 3. HOW TO TAKE PAIDOTERIN ANTIGRIFFAL SYRUP 4. POSSIBLE SIDE EFFECTS 5. STORAGE OF PAIDOTERIN ANTIGRIFFAL SYRUP 6. ADDITIONAL INFORMATION 1. WHAT PAIDOTERIN ANTIGRIFFAL SYRUP IS AND WHAT IT IS USED FOR PAIDOTERIN ANTIGRIFFAL SYRUP IS A COMBINATION OF PHENYLEPHRINE, DIPHENHYDRAMINE, AND CHLORPHENIRAMINE. PHENYLEPHRINE IS A SYMPATHOMIMETIC AMINE THAT ACTS ON ALPHA-ADRENERGIC RECEPTORS IN THE RESPIRATORY TRACT MUCOSA TO CAUSE VASOCONSTRICTION, WHICH TEMPORARILY REDUCES THE SWELLING ASSOCIATED WITH MUCOSAL INFLAMMATION, CLEARING THE NASAL PASSAGES AND ACTING AS A DECONGESTANT. DIPHENHYDRAMINE AND CHLORPHENIRAMINE ARE TWO ANTIHISTAMINES THAT PREVENT, BUT DO NOT CURE, REACTIONS CAUSED BY HISTAMINE. THE ANTIMUSCARINIC EFFECT OF ANTIHISTAMINES PROVIDES A SOOTHING EFFECT ON THE NASAL MUCOSA. IT RELIEVES SWELLING OF THE MUCOSA OF THE UPPER RESPIRATORY TRACT ASSOCIATED WITH ALLERGIC RHINITIS, WHICH OCCURS OVER MANY YEARS OR SEASONAL PERIODS. SEE BLOG: WHAT IS PAIDOTERIN DECONGESTANT AND WHAT IS IT USED FOR? 2. BEFORE TAKING PAIDOTERIN ANTIGRIFFAL SYRUP DO NOT TAKE PAIDOTERIN IF: - YOU ARE HYPERSENSITIVE TO ANY OF THE MEDICINE'S INGREDIENTS - CHILDREN UNDER 2 YEARS OF AGE TAKE SPECIAL CARE WITH PAIDOTERIN ANTIGRIFFAL SYRUP: USE GREAT CAUTION IN PATIENTS WITH HYPERTENSION, SEVERE CARDIOVASCULAR DISEASE, GLAUCOMA, PROSTATE HYPERTROPHY, AS WELL AS PATIENTS WITH PROBLEMS RELATED TO BLADDER AND URINARY RETENTION. PATIENTS SENSITIVE TO ANTIHISTAMINES MAY ALSO BE SENSITIVE TO OTHER AGENTS. TAKING OTHER MEDICINES: ANTIHISTAMINES MAY POTENTIATE THE CNS DEPRESSANT EFFECT WHEN TAKEN WITH CNS DEPRESSANTS, TRICYCLIC ANTIDEPRESSANTS, MAO INHIBITORS, AND ALCOHOL. THEY MAY ALSO POTENTIATE THE ANTICHOLINERGIC EFFECTS OF ANTICHOLINERGIC DRUGS. THE USE OF PHENYLEPHRINE WITH DOXAPRAM, METHYLDOPA, OR TRIMFART MAY POTENTIATE VASOCONSTRICTOR EFFECTS. PHENYLEPHRINE USED WITH DIGITALIS GLYCOSIDES MAY INCREASE THE RISK OF CARDIAC ARRHYTHMIA AND ERGOT ALKALOIDS OR METHYSERGIDE-INDUCED VASOCONSTRICTION. THIS MAY ALSO PROLONG AND POTENTIATE CARDIAC STIMULANT EFFECTS. THE PRESSOR RESPONSE TO PHENYLEPHRINE MAY BE BLOCKED BY PRIOR ADMINISTRATION OF ALPHA-ADRENOCEPTOR BLOCKERS, AND PHENYLEPHRINE MAY BLOCK THE THERAPEUTIC EFFECTS OF BETA-ADRENOCEPTOR BLOCKERS. THE RISK OF ACUTE VENTRICULAR ARRHYTHMIA MAY INCREASE WHEN PHENYLEPHRINE AND ANESTHETIC AGENTS, HALOGENATED HYDROCARBONS BY INHALATION, ARE TAKEN SIMULTANEOUSLY. PAIDOTERIN ANTIGRIFFAL SYRUP IS SUITABLE FOR ANY SULFONAMIDE OR ANTIBIOTIC THERAPY. INFORM YOUR DOCTOR OR PHARMACIST IF YOU ARE TAKING OR HAVE RECENTLY TAKEN ANY MEDICINES, INCLUDING THOSE PURCHASED WITHOUT A PRESCRIPTION. USE IN CHILDREN: NOT FOR USE IN CHILDREN UNDER 2 YEARS OF AGE. USE IN THE ELDERLY: IN THE ELDERLY, CNS STIMULANT ANTICHOLINERGIC EFFECTS MAY OCCUR, AND THERE IS A RISK OF ACCELERATING UNDIAGNOSED GLAUCOMA. PREGNANCY AND LACTATION: THE SAFETY OF PAIDOTERIN ANTIGRIFFAL SYRUP IN PREGNANT WOMEN HAS NOT BEEN ESTABLISHED. IT IS NOT RECOMMENDED FOR USE IN BREASTFEEDING WOMEN, AS IT MAY BE ASSOCIATED WITH ADVERSE EFFECTS ON THE FETUS, SUCH AS UNUSUAL IRRITABILITY AND EXCITEMENT, DUE TO THE SMALL AMOUNT OF ANTIHISTAMINES EXCRETED IN MILK. DRIVING AND OPERATING MACHINERY: AS THE MEDICINE MAY CAUSE DROWSINESS, IT MAY BE HARMFUL AND DANGEROUS WHEN DRIVING. USE IN ATHLETES: THIS MEDICINE CONTAINS PHENYLEPHRINE, WHICH MAY CAUSE A POSITIVE RESULT DURING DOPING TESTS. IMPORTANT INFORMATION ABOUT SOME COMPONENTS OF PAIDOTERIN ANTIGRIFFAL SYRUP: - THIS MEDICINE CONTAINS SUCROSE. IF YOUR DOCTOR HAS INFORMED YOU THAT YOU HAVE AN INTOLERANCE TO CERTAIN TYPES OF SUGAR, CONSULT THEM BEFORE TAKING THE PREPARATION. - MAY CAUSE TOOTH DECAY. - MAY CAUSE ALLERGIC REACTIONS (POSSIBLY DELAYED) AS IT CONTAINS METHYL PARAHYDROXYBENZOATE, SODIUM SALT (E-219). 3. HOW TO TAKE PAIDOTERIN ANTIGRIFFAL SYRUP INSTRUCTIONS FOR PROPER USE: STRICTLY FOLLOW THE DOSAGE INSTRUCTIONS FOR PAIDOTERIN ANTIGRIFFAL SYRUP GIVEN BY YOUR DOCTOR. IF YOU HAVE ANY QUESTIONS OR DOUBTS, CONSULT YOUR DOCTOR OR PHARMACIST. THE RECOMMENDED DOSE IS: FOR CHILDREN AGED 2 TO 6 YEARS: 5 ML EVERY 6 OR 8 HOURS FOR CHILDREN AGED 6 TO 12 YEARS: 10-15 ML EVERY 6 OR 8 HOURS FOR ADULTS: 15-20 ML EVERY 6 OR 8 HOURS IT ACTS BEST WHEN TAKEN AFTER MEALS. DOSAGE IS ADMINISTERED USING THE MEASURING CUP (WITH GRADUATIONS OF 2.5, 5, 15, AND 20 ML) PROVIDED INSIDE OR USING A SMALL SPOON (WITH A VOLUME OF 5 MILLIGRAMS). DO NOT EXCEED THE DOSE, A MAXIMUM OF DOUBLE THE INDICATED DOSE PER ADMINISTRATION. TAKING MORE PAIDOTERIN ANTIGRIFFAL SYRUP THAN PRESCRIBED: IN CASE OF ACUTE INTOXICATION DUE TO OVERDOSE, TREATMENT INCLUDES INDUCING VOMITING OR GASTRIC LAVAGE WITH A 5% SODIUM BICARBONATE SOLUTION, ACTIVATED CHARCOAL, AND PURGATION. IF VENTRICULAR TACHYCARDIA IS OBSERVED, ADMINISTER LIDOCAINE, AND IF THERE IS NO RESPONSE TO IT, PROPRANOLOL. IN CASE OF CONVULSIONS, DIAZEPAM. IN CASE OF ACUTE HYPERTENSION - NITROPRUSSIDE OR PHENTOLAMINE. IF THE ANTICHOLINERGIC EFFECT DOES NOT SUBSIDE, ADMINISTER PHYSOSTIGMINE, PERFORM ELECTROCARDIOGRAPHY, AND IN SYMPTOMATIC PATIENTS, MONITOR URINE AND BLOOD ELECTROLYTES. IN CASE OF OVERDOSE OR ACCIDENTAL INGESTION, CONTACT YOUR DOCTOR OR PHARMACIST IMMEDIATELY OR CALL THE TOXICOLOGICAL INFORMATION SERVICE: TEL- 91 562 04 20, INDICATING THE NAME OF THE MEDICINE AND THE DOSE TAKEN. IF YOU FORGET TO TAKE PAIDOTERIN ANTIGRIFFAL SYRUP: DO NOT TAKE A DOUBLE DOSE TO COMPENSATE FOR THE MISSED DOSE. IF YOU HAVE ANY OTHER DOUBTS REGARDING THIS MEDICINE, CONSULT YOUR DOCTOR OR PHARMACIST. 4. POSSIBLE SIDE EFFECTS LIKE ALL MEDICINES, PAIDOTERIN ANTIGRIFFAL SYRUP MAY CAUSE SIDE EFFECTS, ALTHOUGH THEY MAY NOT OCCUR IN EVERYONE. DROWSINESS IS PARTICULARLY COMMON. RARELY, PATHOLOGICAL BLOOD CHANGES, INCREASED SENSITIVITY TO SUNLIGHT, INCREASED SWEATING, AND LOSS OF APPETITE MAY OCCUR. ALSO, IN RARE CASES, (POOR SLEEP - NIGHTMARES, EXCITEMENT, NERVOUSNESS, ETC.) MAY OCCUR. THERE IS A GREATER CHANCE OF THESE SIDE EFFECTS OCCURRING IN CHILDREN AND THE ELDERLY. THEY ARE MORE LIKELY TO EXPERIENCE DISORDERS, COMPLICATIONS, OR PAIN AND DROWSINESS. IF YOU BELIEVE ANY SIDE EFFECT YOU ARE EXPERIENCING IS SERIOUS, OR IF ANY SIDE EFFECT NOT LISTED IN THIS LEAFLET OCCURS, INFORM YOUR DOCTOR OR PHARMACIST. 5. STORAGE OF PAIDOTERIN ANTIGRIFFAL SYRUP KEEP OUT OF REACH OF CHILDREN. THE BOTTLE SHOULD BE KEPT IN ITS ORIGINAL PACKAGING, PROTECTED FROM LIGHT AND EXCESSIVELY LOW TEMPERATURES. DO NOT USE PAIDOTERIN ANTIGRIFFAL SYRUP AFTER THE EXPIRY DATE INDICATED ON THE PACKAGING. THE EXPIRY DATE REFERS TO THE LAST DAY OF THE MONTH INDICATED THEREIN. MEDICINES SHOULD NOT BE DISPOSED OF DOWN THE DRAIN OR IN THE TRASH. TAKE THEM TO A SPECIAL COLLECTION POINT AT THE PHARMACY. CONTACT YOUR DOCTOR OR PHARMACIST REGARDING THE DISPOSAL OF MEDICINES YOU NO LONGER NEED, THUS HELPING TO PROTECT THE ENVIRONMENT. 6. ADDITIONAL INFORMATION COMPOSITION OF PAIDOTERIN ANTIGRIFFAL SYRUP: 5 ML OF SYRUP CONTAINS: PHENYLEPHRINE HYDROCHLORIDE 5MG; DIPHENHYDRAMINE HYDROCHLORIDE 5 MG, CHLORPHENIRAMINE MALEATE 0.75 MG; (SODIUM SACCHARIN 5 MG; SUCROSE 1.665 MG, STRAWBERRY RED COLORANT, METHYLPARAHYDROXYBENZOATE, SODIUM SALT (E – 219), GLYCERIN, SODIUM CITRATE, STRAWBERRY FLAVORING, DEIONIZED WATER). PRODUCT FORM AND PACKAGING CONTENT: PAIDOTERIN ANTIGRIFFAL SYRUP IS A RED LIQUID WITH A STRAWBERRY FLAVOR, AVAILABLE IN A 100 ML CONTAINER WITH A DOSING CUP.